ATE315380T1 - Epothilon zusammensetzungen - Google Patents

Epothilon zusammensetzungen

Info

Publication number
ATE315380T1
ATE315380T1 AT00949439T AT00949439T ATE315380T1 AT E315380 T1 ATE315380 T1 AT E315380T1 AT 00949439 T AT00949439 T AT 00949439T AT 00949439 T AT00949439 T AT 00949439T AT E315380 T1 ATE315380 T1 AT E315380T1
Authority
AT
Austria
Prior art keywords
epothilone
compositions
liposomal compositions
provides liposomal
provides
Prior art date
Application number
AT00949439T
Other languages
English (en)
Inventor
Jean-Claude Sonntag
Markus Wartmann
Karl-Heinz Altmann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315380(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE315380T1 publication Critical patent/ATE315380T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00949439T 1999-08-04 2000-08-02 Epothilon zusammensetzungen ATE315380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9918429.3A GB9918429D0 (en) 1999-08-04 1999-08-04 Organic compounds

Publications (1)

Publication Number Publication Date
ATE315380T1 true ATE315380T1 (de) 2006-02-15

Family

ID=10858600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949439T ATE315380T1 (de) 1999-08-04 2000-08-02 Epothilon zusammensetzungen

Country Status (8)

Country Link
EP (1) EP1198225B1 (de)
AT (1) ATE315380T1 (de)
AU (1) AU6279500A (de)
DE (1) DE60025494T2 (de)
DK (1) DK1198225T3 (de)
ES (1) ES2254203T3 (de)
GB (1) GB9918429D0 (de)
WO (1) WO2001010412A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (de) 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthese von Epitholonen, Zwischenprodukte, Analoga und ihre Verwendung
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
US6893859B2 (en) 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
AU2003235761A1 (en) * 2002-01-14 2003-07-24 Novartis Ag Combinations comprising epothilones and anti-metabolites
CN1649585A (zh) * 2002-05-01 2005-08-03 诺瓦提斯公司 用于治疗肝脏肿瘤和其它癌症疾病的埃坡霉素衍生物
ES2331791T5 (es) 2002-06-26 2016-01-21 Medigene Ag Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
AU2003264822A1 (en) * 2002-10-11 2004-05-04 Dana-Farber Cancer Institute Inc Epothilone derivatives for the treatment of multiple myeloma
ATE452888T1 (de) 2002-11-07 2010-01-15 Kosan Biosciences Inc Trans-9,10-dehydroepothilon c und d, analoga davon und verfahren zu deren herstellung
US7691838B2 (en) 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
CA2604473A1 (en) 2005-04-29 2006-11-09 Kosan Biosciences Incorporated Method of treating multiple myeloma using 17-aag or 17-ag or a prodrug of either
MX2011010045A (es) * 2009-03-25 2011-10-11 Novartis Ag Composicion farmaceutica que contiene un farmaco y siarn.
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis

Also Published As

Publication number Publication date
WO2001010412A1 (en) 2001-02-15
DE60025494D1 (de) 2006-04-06
GB9918429D0 (en) 1999-10-06
ES2254203T3 (es) 2006-06-16
AU6279500A (en) 2001-03-05
EP1198225A1 (de) 2002-04-24
DK1198225T3 (da) 2006-03-27
EP1198225B1 (de) 2006-01-11
DE60025494T2 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
MXPA03000059A (es) Derivados de pirazol.
EA199900373A2 (ru) Фармацевтические композиции
IT1308628B1 (it) Composizioni fluoroelastomeriche.
MXPA03007315A (es) Composiciones antitranspirantes o desodorantes.
PT1473036E (pt) Solvato de hemitartarato de zolpidem
DK1985626T3 (da) P. gingivalis-antigensammensætning
TR199802240T2 (de)
DE60022980D1 (de) Umgerührte Reibschweissverbindungen enthaltendes Bauelement
NO20023244D0 (no) Hydrogeler
DE60025494D1 (de) Epothilon zusammensetzungen
DZ2815A1 (fr) Inhibiteurs de protéase.
ITTO20020744A1 (it) Composizione.
IT1307264B1 (it) Composizioni insetticide.
BR0103435B1 (pt) composiÇço de tonalizador.
IT1311356B1 (it) Disposizione di macchine.
IT1318819B1 (it) Amplificatore di corrente
DE50115802D1 (de) Dafür
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
HN2000000084A (es) Inhibidores de metaloproteasa.
CY1115144T1 (el) Παραγωγα του uk-2a
ES1048844Y (es) Cupon precinto desprendible de cajas de medicamentos.
IT1304174B1 (it) Composizioni perossidiche
FI981420A0 (fi) Jatkopistokytkin
ITCS990005V0 (it) Sila sorgente di policaretto.
BR0000061B1 (pt) conjunto de montagem de marcos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1198225

Country of ref document: EP